Seahorse Bioscience is a private company that develops and manufactures cellular bioenergetics analytical instruments. Seahorse also manufactures consumable labware products, and consumables for measuring cell metabolism. The company was formerly known as Thermogenic Imaging. Recognized for developing novel, leading-edge cellular bioenergetic technologies, the company is best known for developing the XF Extracellular Flux Analyzer.

XF technology makes cellular bioenergetic studies simple, efficient and user-friendly by combining an electro-optical instrument with ‘smart plastic’ cartridges that enable the real-time measurement of cellular bioenergetics in a non-invasive, multi-well microplate format.

The first in vitro metabolic measurement, XF technology non-invasively profiles the metabolic activity of cells in minutes, offering scientists a physiologic cell-based assay for the determination of basal oxygen consumption, glycolysis rates, ATP production, and respiratory capacity in a single experiment to assess mitochondrial dysfunction.

Company President and CEO, Jay Teich founded the company in 2001 along with Andy Neilson and Jim Orrell. Seahorse Bioscience is headquartered in North Billerica, Massachusetts, with its manufacturing facility in Chicopee, Massachusetts, and international offices in Shanghai, China and Copenhagen, Denmark. In early 2016, Seahorse Bioscience was acquired by Agilent Technologies.